FDA Inspection 1195342 — Anicare Pharmaceuticals Pvt Ltd.
The FDA completed an inspection of Anicare Pharmaceuticals Pvt Ltd. on January 20, 2023 in Navi Mumbai. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 9 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- January 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Navi Mumbai (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1213 | 21 CFR 211.67(a) | Cleaning / Sanitizing / Maintenance |
| 1263 | 21 CFR 211.68(b) | Computer control of master formula records |
| 1413 | 21 CFR 211.42(c)(5) | Mfg / Processing Operations Area |
| 1885 | 21 CFR 211.165(b) | Microbiological testing |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2031 | 21 CFR 211.194(a) | Complete test data included in records |
| 4321 | 21 CFR 211.101(b) | Identification of new containers |
| 4342 | 21 CFR 211.142(b) | Storage under appropriate conditions |